Psychedelics Education & Training: What Operators & Educators Need to Know

Zealand drug hit with CRL for ultra-rare disease amid manufacturing concerns, plans to resubmit in 2024

The FDA rejected Zealand Pharma’s glucagon receptor agonist in congenital hyperinsulinism (CHI) after identifying problems at a third-party manufacturing site. The company said it remains

December 29, 2023

Stress of neighborhood poverty and community violence affects Black adolescents’ mental health

It’s easy to imagine that growing up in a neighborhood with safe and clean parks, little to no discrimination, and where people are not struggling

August 2, 2023

EMA reviews hair loss products following concerns about suicidal thoughts

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.